+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Botulinum Toxin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026

  • ID: 4851555
  • Report
  • November 2018
  • Region: Global
  • 172 pages
  • Transparency Market Research
1 of 2

Global Botulinum Toxin Market: Overview

This report analyzes the current and future scenario of the global botulinum toxin market. Botulinum toxin is a neurotoxin that is produced by the bacterium clostridium botulinum. There are around eight types of botulinum toxins A-H, produced by the bacterium. Botulinum toxin type A is capable of causing diseases in humans; however, it is widely utilized commercially and medically for the treatment of several aesthetic diseases such as glabellar lines, crow’s foot, and face and forehead wrinkles. Botulinum toxin is also utilized in the therapeutic treatment of spasticity, cervical dystonia, and migraine. Botulinum toxin procedure is a non-surgical cosmetic procedure that is noninvasive or minimally invasive in nature. Botulinum toxin procedure is a non-surgical and noninvasive or minimally invasive and has several advantages, such as no downtime, less time of surgery, no need of hospitalization, and faster recovery, over conventional cosmetic or aesthetic surgeries.

The global botulinum toxin market is expanding at a high pace owing to the increase in prevalence of cervical dystonia and upper limb and lower limb spasticity. Rise in global geriatric population and adoption of new non-surgical aesthetic procedures is fuelling the market. Growing incidences of glabellar lines, face and forehead wrinkles, and crow’s foot and consistent worldwide rise in cases of migraine are boosting the market. Furthermore, rising number of skilled professionals performing non-surgical botulinum toxin procedures, favorable government regulations regarding the commercial usage of botulinum toxins, and advantages of faster onset of action of botulinum toxin procedure over traditional cosmetic procedure are propelling the botulinum toxin market.

This report on the global botulinum toxin market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on product type, application, and region. A detailed qualitative analysis of drivers, restraints, opportunities and trends of the market has been provided in the overview section. Additionally, the market outlook section offer key insights of the global market such as price comparison analysis, pipeline analysis and launch & patent expiry snapshot. It also provides market attractiveness analysis, in terms of region and key strategies adopted by players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global botulinum toxin market.

Global Botulinum Toxin Market: Key Segments

Botulinum toxin market has segmented into product type, application, and region. Based on product type, the botulinum toxin market has been classified into botulinum toxin type A and botulinum toxin type B. Based on application, the market has been bifurcated into aesthetic and therapeutics, which are the main application areas of the market. Each of the segments has been analyzed in detail in terms of market trends, recent developments, drivers, restraints, opportunities, and useful insights. The report gives current and future market size for each segment and sub-segment of the market for the period of 2018 to 2026, in terms of revenue depicted in US$ Mn, considering 2017 as the base year and 2016 as the historical year. The compound annual growth rate (CAGR) has been provided for each segment and the overall market for the period of 2018 to 2026, along with market size estimations.

Global Botulinum Toxin Market: Regional Outlook

In terms of region, the global botulinum toxin market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further sub-segmented into major countries and sub-regions. The current and future market size, in terms of value, of the botulinum toxin market at the regional and country level has been provided in the report for the period of 2016 to 2026, along with their growth rate in percentage for the period of 2018 to 2026. The study also provides useful insights of the market, expected to help new companies willing to enter the market and existing companies seeking to increase their market share.

Companies Mentioned in the Report

The report profiles major companies operating in the global botulinum toxin market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, recent developments, and SWOT (strength, weakness, opportunity, and threat) analysis. Major companies mentioned are Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc. (US), Lanzhou Institute of Biological Products Co. Ltd., and Revance Therapeutics, Inc.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Botulinum Toxin Market

4. Market Overview
4.1. Introduction
4.1.1. by Product Type Definition
4.1.2. Market Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increasing demand for minimally invasive and non-invasive aesthetic and therapeutic procedures
4.3.1.2. Increase in prevalence of spasticity and cervical dystonia
4.3.1.3. Increasing number of products approval and new product launch in different region
4.3.1.4. Rising awareness regarding botulinum toxin procedures in the geriatric population worldwide
4.3.2. Restraints
4.3.2.1. Short time results and repetitive nature of aesthetic and therapeutic procedures
4.3.2.2. High cost of procedures and unavailability of reimbursement policies
4.3.3. Opportunities
4.3.3.1. Use of botulinum toxin products for the treatment of migraine and over sweating
4.3.3.2. Numerous products in phase III and above clinical trials for various disease conditions
4.4. Global Botulinum Toxin Market Analysis and Forecast, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Price Comparison Analysis (2017)
5.2. Pipeline Analysis
5.3. Launch and Patent Expiry - Snapshot
5.4. Key Trends
5.4.1. Increasing use of botulinum toxin aesthetic treatments by men
5.4.2. New and improved approaches regarding formulation types and delivery of botulinum toxin products

6. Global Botulinum Toxin Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
6.3.1. Botulinum Toxin Type A
6.3.2. Botulinum Toxin Type B
6.4. Market Attractiveness by Product Type

7. Global Botulinum Toxin Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Botulinum Toxin Market Value Forecast, by Application, 2016-2026
7.3.1. Aesthetic
7.3.2. Therapeutics
7.4. Global Botulinum Toxin Market Attractiveness, by Application

8. Global Botulinum Toxin Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Botulinum Toxin Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Botulinum Toxin Market Attractiveness, by Region

9. North America Botulinum Toxin Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
9.2.1. Botulinum Toxin Type A
9.2.2. Botulinum Toxin Type B
9.3. North America Botulinum Toxin Market Value Forecast, by Application, 2016-2026
9.3.1. Aesthetic
9.3.2. Therapeutics
9.4. North America Botulinum Toxin Market Value Forecast, by Country, 2016-2026
9.4.1. U.S.
9.4.2. Canada
9.5. North America Botulinum Toxin Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Application
9.5.3. By Country

10. Europe Botulinum Toxin Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
10.2.1. Botulinum Toxin Type A
10.2.2. Botulinum Toxin Type B
10.3. Europe Botulinum Toxin Market Value Forecast, by Application, 2016-2026
10.3.1. Aesthetic
10.3.2. Therapeutics
10.4. Europe Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016-2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Botulinum Toxin Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Application
10.5.3. By Country/Region

11. Asia Pacific Botulinum Toxin Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
11.2.1. Botulinum Toxin Type A
11.2.2. Botulinum Toxin Type B
11.3. Asia Pacific Botulinum Toxin Market Value Forecast, by Application, 2016-2026
11.3.1. Aesthetic
11.3.2. Therapeutics
11.4. Asia Pacific Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016-2026
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Rest of Asia Pacific
11.5. Asia Pacific Botulinum Toxin Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Application
11.5.3. By Country/Region

12. Latin America Botulinum Toxin Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
12.2.1. Botulinum Toxin Type A
12.2.2. Botulinum Toxin Type B
12.3. Latin America Botulinum Toxin Market Value Forecast, by Application, 2016-2026
12.3.1. Aesthetic
12.3.2. Therapeutics
12.4. Latin America Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016-2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Botulinum Toxin Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Application
12.5.3. By Country/Sub-region

13. Middle East & Africa Botulinum Toxin Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
13.2.1. Botulinum Toxin Type A
13.2.2. Botulinum Toxin Type B
13.3. Middle East & Africa Botulinum Toxin Market Value Forecast, by Application, 2016-2026
13.3.1. Aesthetic
13.3.2. Therapeutics
13.4. Middle East & Africa Botulinum Toxin Market Value Forecast, by Country/Region, 2016-2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Botulinum Toxin Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By Application
13.5.3. By Country/Sub-region

14. Competition Landscape
14.1. Market Player - Competition Matrix (by Tier and Size of companies)
14.2. Market Share Analysis by Company (2017)
14.3. Company Profiles
14.3.1. Allergan, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Ipsen Group
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Medytox, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Merz Pharma GmbH & Co. KGaA
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. US Worldmed, LLC
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.6. Nestlé Skin Health (Galderma)
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Metabiologics, Inc. (US)
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.8. Hugel Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Lanzhou Institute of Biological Products Co. Ltd.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Revance Therapeutics, Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll